Nuclear factor-κB accounts for the repressor effects of high stromal cell-derived factor-1α levels on Tac1 expression in nontumorigenic breast cells

Molecular Cancer Research

Volumn 5, Issue 4, 2007, Pages 373-381

  Corcoran, Kelly E ^a   Rameshwar, Pranela ^b  

^a The State University of New Jersey   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2 RECEPTOR ALPHA; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; STROMAL CELL DERIVED FACTOR 1ALPHA; SUBSTANCE P; ALPHA CHEMOKINE; STROMAL CELL DERIVED FACTOR 1; TACHYKININ;

ARTICLE; BREAST CELL; CANCER CELL CULTURE; CONTROLLED STUDY; DNA FLANKING REGION; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXON; GENE ACTIVITY; GENE INDUCTION; HUMAN; HUMAN CELL; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE; WESTERN BLOTTING; BIOLOGICAL MODEL; BREAST; CELL LINE; CYTOLOGY; DOSE RESPONSE; GENETIC TRANSFECTION; GENETICS; METABOLISM; PHYSIOLOGY;

5' FLANKING REGION; BLOTTING, WESTERN; BREAST; CELL LINE; CHEMOKINES, CXC; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MODELS, BIOLOGICAL; NF-KAPPA B; RECEPTORS, CXCR4; SUBSTANCE P; TACHYKININS; TRANSFECTION;

EID: 34248171306     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-06-0396     Document Type: Article

References (40)

1. Ganju RK, Brubaker SA, Meyer J, et al. The α-chemokine, stromal cell-derived factor-1α, binds to the transmembrane G-protein-coupled CXCR-4 receptor and activates multiple signal transduction pathways. J Biol Chem 1998;273:23169-75.
2. Davis DA, Singer DE, Sierra DM, et al. Identification of carboxypeptidase N as an enzyme responsible for C-terminal cleavage of stromal cell-derived factor-1α in the circulation. Blood 2005;105:4561-8.
3. De La LuzSierra M, Yang F, Narazaki M, et al. Differential processing of stromal-derived factor-1α and stromal-derived factor-1β explains functional diversity. Blood 2004;103:2452-9.
4. Wang JF, Park IW, Groopman JE. Stromal cell-derived factor-1α stimulates tyrosine phosphorylation of multiple focal adhesion proteins and induces migration of hematopoietic progenitor cells: roles of phosphoinositide-3 kinase and protein kinase C. Blood 2000;95:2505-13.
5. Nagasawa T, Kikutani H, Kishimoto T. Molecular cloning and structure of a pre-B-cell growth stimulating factor. Proc Natl Acad Sci U S A 1994;91:2305-9.
6. Gazitt Y. Homing and mobilization of hematopoietic stem cells and hematopoietic cancer cells are mirror image processes, utilizing similar signaling pathways and occurring concurrently: circulating cancer cells constitute an ideal target for concurrent treatment with chemotherapy and anti-lineage specific antibodies. Leukemia 2004;18:1-10.
7. Corcoran KE, Patel N, Rameshwar P. Stromal derived growth factor-1α: another mediator in neural-emerging immune system through Tac1 expression in bone marrow stromal cells. J Immunol 2007;178:2075-82.
8. Singh D, Joshi DD, Hameed M, et al. Increased expression of preprotachykinin-I and neurokinin receptors in human breast cancer cells: implications for BM metastasis. Proc Natl Acad Sci U S A 2000;97:388-93.
9. Bellucci F, Carini F, Catalani C, et al. Pharmacological profile of the novel mammalian tachykinin, hemokinin 1. Br J Pharmacol 2002;135:266-74.
10. Greco SJ, Corcoran KE, Trzaska KA, Rameshwar P. Tachykinins in the emerging immune system: relevance to bone marrow homeostasis and maintenance of hematopoietic stem cells. Front Biosci 2004;9:1782-93.
11. Kang HS, Trzaska KA, Corcoran K, et al. Neurokinin receptors: relevance to the emerging immune system. Arch Immunol Ther Exp (Warsz) 2004;52:338-47.
12. Castro TA, Cohen MC, Rameshwar P. The expression of neurokinin-1 and preprotachykinin-1 in breast cancer cells depends on the relative degree of invasive and metastatic potential. Clin Exp Metastasis 2005;22:621-8.
13. Bandari PS, Qian J, Oh HS, et al. Crosstalk between neurokinin receptors is relevant to hematopoietic regulation: cloning and characterization of neurokinin-2 promoter. J Neuroimmunol 2003;138:65-75.
14. Rao G, Patel PS, Idler SP, et al. Facilitating role of preprotachykinin-I gene in the integration of breast cancer cells within the stromal compartment of the bone marrow: a model of early cancer progression. Cancer Res 2004;64:6327-31.
15. Oh HS, Moharita A, Potian JG, et al. Bone marrow stroma influences transforming growth factor-β production in breast cancer cells to regulate c-myc activation of the preprotachykinin-I gene in breast cancer cells. Cancer Res 2004;64:6327-36.
16. Moharita A, Harrison JS, Rameshwar P. Neurokinin receptors and subtypes as potential targets in breast cancer: relevance to bone marrow metastasis. Drug Des Rev Online 2004;1:297-302.
17. Mukerji I, Ramkissoon SH, Reddy KK, Rameshwar P. Autocrine proliferation of neuroblastoma cells is partly mediated through neurokinin receptors: relevance to bone marrow metastasis. J Neurooncol 2005;71:91-8.
18. Aalto Y, Forsgren S, Kjorell U, Bergh J, Franzen L, Henriksson R. Enhanced expression of neuropeptides in human breast cancer cell lines following irradiation. Peptides 1998;19:231-9.
19. Qian J, Ramroop K, McLeod A, et al. Induction of hypoxia-inducible factor-1α and activation of caspase-3 in hypoxia-reoxygenated bone marrow stroma is negatively regulated by the delayed production of substance P. J Immunol 2001;167:4600-8.
20. Rameshwar P, Gascon P. Induction of negative hematopoietic regulators by neurokinin-A in bone marrow stroma. Blood 1996;88:98-106.
21. Fan TP, Hu DE, Guard S, Gresham GA, Watling KJ. Stimulation of angiogenesis by substance P and interleukin-1 in the rat and its inhibition by NK1 or interleukin-1 receptor antagonists. Br J Pharmacol 1993;110:43-9.
22. Patel H, Ramkissoon SH, Patel PS, Rameshwar P. Transformation of breast cells by truncated neurokinin-1 receptor is secondary to activation by preprotachykinin-I peptides. Proc Natl Acad Sci U S A 2005;102:17436-41.
23. Muller A, Homey B, Soto H, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001;410:50-6.
24. Kato M, Kitayama J, Kazama S, Nagawa H. Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma. Breast Cancer Res 2003;5:R144-50.
25. Mori T, Doi R, Koizumi M, et al. CXCR4 antagonist inhibits stromal cell-derived factor 1-induced migration and invasion of human pancreatic cancer. Mol Cancer Ther 2004;3:29-37.
26. Moharita AL, Taborga M, Corcoran KE, Bryan M, Patel PS, Rameshwar P. SDF-1α regulation in breast cancer cells contacting bone marrow stroma is critical for normal hematopoiesis. Blood 2006;108:3245-52.
27. Lapteva N, Yang AG, Strube RW, Sanders DE. CXCR4 knockdown by small interfering RNA abrogates breast tumor growth in vivo. Cancer Gene Ther 2005;12:84-9.
28. Qian J, Yehia G, Molina C, et al. Cloning of human preprotachykinin-I promoter and the role of cyclic adenosine 5′-monophosphate response elements in its expression by IL-1 and stem cell factor. J Immunol 2001;166:2553-61.
29. Rameshwar P, Poddar A, Zhu G, Gascon P. Receptor induction regulates the synergistic effects of substance P with IL-1 and PDGF on the proliferation of bone marrow fibroblasts. J Immunol 1997;158:3417-24.
30. Roland J, Murphy BJ, Ahr B, et al. Role of the intracellular domains of CXCR4 in SDF-1-mediated signaling. Blood 2003;101:399-406.
31. Dar A, Goichberg P, Shinder V, et al. Chemokine receptor CXCR4-dependent internalization and resecretion of functional chemokine SDF-1 by bone marrow endothelial and stromal cells. Nat Immunol 2005;6:1038-46.
32. Sotsios Y, Whittaker GC, Westwick J, Ward SG. The CXC chemokine stromal cell-derived factor activates a Gi-coupled phosphoinositide 3-kinase in T lymphocytes. J Immunol 1999;163:5954-63.
33. Chandrasekar B, Bysani S, Mummidi S. CXCL16 signals via Gi, phosphatidylinositol 3-kinase, Akt, IκB kinase, and nuclear factor-κB and induces cell-cell adhesion and aortic smooth muscle cell proliferation. J Biol Chem 2004;279:3188-96.
34. Braun S, Vogl FD, Naume B, et al. A pooled analysis of bone marrow micrometastasis in breast cancer. N Engl J Med 2005;353:793-802.
35. Lapidot T, Dar A, Kollet O. How do stem cells find their way home? Blood 2005;106:1901-10.
36. Kucia M, Reca R, Miekus K, et al. Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis. Stem Cells 2005;7:879-94.
37. Petit I, Szyper-Kravitz M, Nagler A, et al. G-CSF induces stem cell mobilization by decreasing in bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol 2002;3:687-94.
38. Helbig G, Christopherson KW, Bhat-Nakshatri P, et al. NF-κB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4. J Biol Chem 2003;278:21631-8.
39. Karin M, Cao Y, Greten FR, Li ZW. NF-κB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2002;4:301-10.
40. Dorrello NV, Peschiaroli A, Guardavaccaro D, Colburn NH, Sherman NE, Pagano M. S6K1- and βTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth. Science 2006;314:467-71.